Overview

Streptococcus is a genus of spherical, Gram-positive bacteria that includes harmless commensals, economically important fermenters and significant human and animal pathogens. Members are commonly called streptococci and are placed in the phylum Firmicutes; many are grouped with lactic acid bacteria because they ferment sugars to lactic acid. The genus name derives from the Greek στρεπτος (streptos), meaning twisted or in chains, a reference to the typical cellular arrangement.

Morphology and physiology

Streptococci are cocci (round cells) that characteristically divide along a single plane, producing chains or pairs rather than clusters. They stain Gram-positive and are oxidase-negative and catalase-negative, features used in basic laboratory differentiation. Many streptococci are facultative anaerobes and obtain energy principally by fermentative metabolism; several species are important lactic acid bacteria in food production.

  • Cell shape: spherical (cocci) with a tendency to form chains or diplococci; see a general note on cocci shape and circular appearance form.
  • Division: division along a single axis explains chain formation; for cellular division details see cell division.
  • Enzymes: catalase-negative (useful to distinguish from staphylococci staphylococci). Many are facultative anaerobes and ferment sugars to lactic acid (lactic acid bacteria).

Taxonomy and historical context

Streptococcus belongs to the Firmicutes phylum Firmicutes. Classical clinical taxonomy used hemolysis on blood agar (alpha, beta, gamma) and Lancefield carbohydrate grouping; modern classification increasingly relies on genetic and molecular markers to define species and subspecies. The Greek origin of the name is often cited in taxonomic histories etymology.

Major groups and notable species

Clinically important streptococci include several distinct groups:

  • Group A Streptococcus (GAS) – mainly Streptococcus pyogenes, causes pharyngitis, skin infections, scarlet fever and can trigger post-infectious immune complications.
  • Group B Streptococcus (GBS) – Streptococcus agalactiae, a frequent cause of neonatal sepsis and meningitis and an infection risk in pregnant women and some adults with underlying conditions.
  • Streptococcus pneumoniae – an alpha-hemolytic diplococcus that commonly causes pneumonia, meningitis and otitis media; distinguished by optochin sensitivity and bile solubility in the laboratory.
  • Viridans streptococci – a diverse group of mainly oral commensals implicated in dental disease and, when they enter the bloodstream, infective endocarditis.

Pathogenesis and clinical importance

Pathogenic streptococci display a range of virulence mechanisms including adhesins, capsules, extracellular enzymes and, in some species, exotoxins. S. pyogenes produces factors that permit tissue invasion and immune modulation; untreated or severe infections can lead to immune-mediated sequelae. S. pneumoniae’s polysaccharide capsule is a key virulence determinant and the target of several vaccines. Clinical presentations span localized mucosal infections to invasive systemic disease.

Diagnosis and laboratory identification

Clinical laboratories combine microscopy, culture and simple biochemical tests to identify streptococci. Blood agar hemolysis pattern is a first step; bacitracin sensitivity suggests Group A, optochin sensitivity and bile solubility indicate S. pneumoniae, and Lancefield grouping detects certain beta-hemolytic strains. Molecular tests and mass spectrometry provide faster and more specific identification in many settings. For broader comparisons between streptococci and other Gram-positive cocci see summaries of Gram-positive bacteria resources and taxonomic outlines taxonomic guides.

Treatment, prevention and public health

Many streptococcal infections remain treatable with beta-lactam antibiotics such as penicillin; however, antimicrobial resistance is an important and evolving concern for some species. Vaccination has substantially reduced disease from several pneumococcal serotypes, and prenatal screening for Group B streptococcus with intrapartum antibiotics has reduced neonatal disease. Public-health measures, timely diagnosis and appropriate antimicrobial stewardship are central to control.

Ecology, industrial uses and research

Beyond disease, streptococci include species used in food fermentation and dairy production as lactic acid bacteria. Oral and skin streptococci are part of normal human microbiota and contribute to ecological balance and niche competition; under certain conditions they can become opportunistic pathogens. Current research addresses vaccine development, mechanisms of virulence, the role of microbiomes in colonization, and improved diagnostic methods. For comparisons with cluster-forming cocci see contrasts with staphylococci comparison and additional background on lactic acid fermenters fermentation microbes.

For concise background reading, overviews of Gram-positive organisms are available via general summaries Gram-positive overview, and detailed taxonomic resources can be consulted through curated outlines taxonomic outline. Historical and etymological notes about chain formation and the genus name appear in classical descriptions name origin.